|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 213.20 EUR | +0.57% |
|
-2.93% | +8.38% |
| 08-07 | Haisco Pharmaceutical Gets China Clinical Trial Nod for Migraine Treatment; Shares Rise 4% | MT |
| 08-06 | RemeGen Expects to Return to Profit in H1; Hong Kong Shares Down 3% | MT |
| Market Cap | 435B 376B 351B 322B 606B 41,379B 616B 4,121B 1,617B 20,740B 1,633B 1,597B 68,566B | P/E 2026 * |
31.4x | P/E 2027 * | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 495B 428B 400B 367B 690B 47,121B 701B 4,692B 1,842B 23,618B 1,859B 1,819B 78,081B | EV / Sales 2026 * |
7.33x | EV / Sales 2027 * | 6.61x |
| Free-Float |
95.71% | Yield 2026 * |
2.79% | Yield 2027 * | 2.94% |
Last Transcript: AbbVie Inc.
| 1 week | -2.93% | ||
| Current month | -2.93% | ||
| 1 month | -5.02% | ||
| 3 months | +23.01% | ||
| 6 months | +12.17% | ||
| Current year | +8.38% |
| 1 week | 209.8 |  | 220.2 |
| 1 month | 209.8 | | 234.6 |
| 3 years | 125.4 | | 234.6 |
| 5 years | 89.97 | | 234.6 |
| 10 years | 50.17 | | 234.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 74 | 2012-12-31 |
Ed Rapp
BRD | Director/Board Member | 69 | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.57% | -2.93% | +24.85% | +55.20% | 435B | |
| -0.52% | +3.21% | +89.52% | +125.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.79% | 625B | |
| +0.89% | -1.95% | +24.23% | +63.19% | 435B | |
| +0.67% | +3.85% | +50.10% | +38.52% | 363B | |
| -0.06% | +1.11% | +31.10% | +38.97% | 296B | |
| -0.03% | +3.54% | +7.89% | +6.67% | 249B | |
| +1.51% | +6.69% | +42.58% | +58.47% | 222B | |
| -1.04% | -0.17% | -6.45% | -51.63% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.16% | 165B | |
| Average | +0.50% | +0.94% | +32.49% | +45.07% | 402.31B | |
| Weighted average by Cap. | +0.44% | +1.33% | +45.94% | +62.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.58B 58.46B 54.59B 50.08B 94.19B 6,432B 95.69B 640B 251B 3,224B 254B 248B 10,658B | 73.51B 63.59B 59.38B 54.47B 102B 6,996B 104B 697B 273B 3,507B 276B 270B 11,593B |
| Net income | 13.85B 11.98B 11.19B 10.26B 19.31B 1,318B 19.61B 131B 51.53B 661B 52.02B 50.88B 2,185B | 18.9B 16.35B 15.27B 14.01B 26.34B 1,799B 26.76B 179B 70.31B 902B 70.98B 69.42B 2,981B |
| Net Debt | 60.33B 52.19B 48.74B 44.71B 84.09B 5,742B 85.43B 572B 224B 2,878B 227B 222B 9,515B | 51.47B 44.52B 41.57B 38.14B 71.73B 4,898B 72.87B 488B 191B 2,455B 193B 189B 8,117B |
| Date | Price | Change |
|---|---|---|
| 26-08-10 | €212.60 | +0.28% |
| 26-08-07 | €212.00 | +0.38% |
| 26-08-06 | €211.20 | -0.71% |
| 26-08-05 | €212.70 | +0.71% |
| 26-08-04 | €211.20 | -1.03% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
- 4AB Stock
Select your edition
All financial news and data tailored to specific country editions
